Back to 
Balyasny Asset Management L.P.
Balyasny Asset Management L.P.
XLO
8 quarters
Position history for Balyasny Asset Management L.P.'s holdings in Xilio Therapeutics, Inc.
No. Balyasny Asset Management exited its XLO (Xilio Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 198,859 shares worth $167,578. Balyasny Asset Management first reported XLO in Q1 2024 and held it in 7 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$365,625
Total Shares Change
-338,542
Quarter-by-Quarter History
Other major holders of XLO: FMR LLC, RA Capital Management, L.P.